Physician
Hematology
Dr. William L. Dahut, MD
|
|
Give Review
William L. Dahut, MD works in the field of Hematology. He attended Georgetown University School of Medicine. Georgetown University School of Medicine has a rank of 49 in research and a 84 in primary care William Dahut has written publications. He has 72 publications published with PubMed. The lastest publication is: 'Sorafenib-Induced Eruption Mimicking Erythema Multiforme.'
Publications
- Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
- Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
- Abiraterone's efficacy confirmed; time to aim higher.
- Tyrosine kinase inhibitors in the treatment of Prostate cancer: taking the next step in clinical development.
- Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib.
- Real-world experience with abiraterone.
- A combination trial of vaccine plus ipilimumab in metastatic castration-resistant Prostate cancer patients: immune correlates.
- Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for Prostate cancer.
- Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive Prostate cancer.
- Is It Time to Reevaluate Definitive Therapy in Prostate Cancer?
- Phase II clinical trial of cediranib in patients with metastatic castration-resistant Prostate cancer.
- The Kinetics and Reproducibility of 18F-Sodium Fluoride for Oncology Using Current PET Camera Technology.
- A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer.
- Overcoming chemotherapy resistance in Prostate cancer.
- Population pharmacokinetic analysis of sorafenib in patients with solid tumours.
- Genetic polymorphisms in XRCC1 associated with radiation therapy in Prostate cancer.
- Novel Androgen Deprivation Therapy (ADT) in the Treatment of Advanced Prostate Cancer.
- A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant Prostate cancer.
- Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant Prostate cancer.
- Treatment of castration-resistant Prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.
- Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant Prostate cancer.
- Therapeutic cancer vaccines in Prostate cancer: the paradox of improved survival without changes in time to progression.
- Reversal of docetaxel resistance with bevacizumab and thalidomide.
- Phase I study of oral lenalidomide in patients with refractory metastatic Cancer.
- A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent Prostate cancer treated with intermittent androgen ablation.
- Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.
- Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant Prostate cancer treated with anti-angiogenic agents.
- Anti-angiogenesis approach to genitourinary Cancer treatment.
- Coevolution of Prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.
- Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
- Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic Prostate cancer.
- Safety and immunologic response of a viral vaccine to Prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an ...
- The genetics of castration-resistant Prostate cancer: what can the germline tell us?
- Analysis of overall survival in patients with nonmetastatic castration-resistant Prostate cancer treated with vaccine, nilutamide, and combination therapy.
- Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel.
- Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic Cancer.
- Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma.
- A phase II clinical trial of sorafenib in androgen-independent Prostate cancer.
- The role of angiogenesis inhibitors in Prostate cancer.
- Association of the CYP1B1*3 allele with survival in patients with Prostate cancer receiving docetaxel.
- Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent Prostate cancer and extensive bone metastases.
- Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent Prostate cancer.
- Characterization of in vitro and in vivo metabolic pathways of the investigational antiCancer agent, 2-methoxyestradiol.
- Phase I trial of an enhanced Prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent Prostate cancer.
- Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.
- Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?
- Early treatment gets the benefit.
- Immunotherapy for Prostate cancer: what's the future?
- The use of thalidomide in androgen-independent Prostate cancer.
- Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors.
- Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent Prostate cancer.
- A phase II study of perifosine in androgen independent Prostate cancer.
- Androgen deprivation therapy for Prostate cancer.
- A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinica...
- A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent Prostate cancer and bone metastases.
- Genotyping and functional analysis of the D104N variant of human endostatin.
- Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry.
- Determination of the antiangiogenesis agent 2-methoxyestradiol in human plasma by liquid chromatography with ultraviolet detection.
- Randomized phase II trial of docetaxel plus thalidomide in androgen-independent Prostate cancer.
- Chemotherapy for Prostate cancer: finally an advance!
- Novel therapeutic strategies in Prostate cancer.
- A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic Cancer.
- The emerging role of bisphosphonates in Prostate cancer.
- Novel approaches to treating the asymptomatic hormone-refractory Prostate cancer patient.
- The combination of antiangiogenic and cytotoxic agents in the treatment of Prostate cancer.
- Pulmonary toxicity during Prostate cancer treatment with docetaxel and thalidomide.
- Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent Prostate cancer.
- Treatment options for androgen-independent Prostate cancer.
- Docetaxel and thalidomide as a treatment option for androgen- independent, nonmetastatic Prostate cancer.
- Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide.
- Approaches to inhibit invasiveness and metastasis in Prostate cancer.
Schools
Georgetown University
Nat39l Naval Med Center
Naval Reg Med Center
Conditions Treated
- Anemia
- Prostate Cancer
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Georgetown University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Irina Maric |
|
|
Dr. Adrian M. Senderowicz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Edwin P. Rock, MD |
|
|
Dr. Alain Thibault, MD |
|
|
Dr. David A. Cooney, MD |
|
|
Dr. Robert A. Sokolic, MD |
|
|
Dr. Jeffery L. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi A. Madan, MD |
|
|
Dr. James N. Kochenderfer, MD |
|
|
Dr. Elad Sharon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay N. Lozier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacinta D. Arrington, MD
This Doctor is OpenDoctor Recommended.
|